Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin-stimulated peripheral blood mononuclear cells. (Inhibitory effects of ribavirin on cytokine production)
- PMID: 15505595
- PMCID: PMC7194803
- DOI: 10.1016/S1665-2681(19)32102-7
Effects of ribavirin on cytokine production of recall antigens and phytohemaglutinin-stimulated peripheral blood mononuclear cells. (Inhibitory effects of ribavirin on cytokine production)
Abstract
Aim: To evaluate the effects of ribavirin on cytokine production of recall antigen and PHA-stimulated PBMC obtained from healthy individuals.
Materials and methods: PBMC were challenged with tetanus toxoid (5 microg/mL) and PHA (10 microg/mL) in absence or presence of ribavirin at different concentrations (1, 10 and 100 (microM). Parallel sets of wells containing PBMC exposed to medium alone were used as negative controls. On day 3 after initiation of the cultures, IL-2, IFN-gamma, IL-4, IL-10, TNF-alpha content were determined in supernatants of PBMC from the different individuals.
Results: The effects of ribavirin on cytokine released by human PBMC in response to PHA and TT showed a great variation among individuals. No significant changes were observed between 1-10 microM concentrations in the production of TNF-alpha, IFN-gamma and IL-10 by both PHA and TT-stimulated PBMC. Ribavirin inhibited TNF-alpha, IFN-gamma, and IL-10 in both PHA and TT-stimulated PBMC at 100 microM (p <0.05). At this concentration, ribavirin induced an increase of 124% in the production of IL-2 by PHA-stimulated PBMC (p <0.05).
Conclusions: The present data suggest that ribavirin may cause diverse effects on immunoregulatory cytokine secretion with changes in the Th1/Th2 balance.
Figures
Similar articles
-
Study of the Th1/Th2 balance, including IL-10 production, in cultures of peripheral blood mononuclear cells from birch-pollen-allergic patients.Allergy. 2000 Feb;55(2):171-5. doi: 10.1034/j.1398-9995.2000.00244.x. Allergy. 2000. PMID: 10726732
-
Effects of natural eggshell membrane (NEM) on cytokine production in cultures of peripheral blood mononuclear cells: increased suppression of tumor necrosis factor-α levels after in vitro digestion.J Med Food. 2012 Apr;15(4):360-8. doi: 10.1089/jmf.2011.0197. Epub 2011 Dec 14. J Med Food. 2012. PMID: 22168811 Free PMC article.
-
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation.Cytokine. 1992 May;4(3):239-48. doi: 10.1016/1043-4666(92)90062-v. Cytokine. 1992. PMID: 1498259
-
Alterations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients.Clin Diagn Lab Immunol. 1995 Nov;2(6):766-9. doi: 10.1128/cdli.2.6.766-769.1995. Clin Diagn Lab Immunol. 1995. PMID: 8574845 Free PMC article.
-
[Modulation of cytokine production from human mononuclear cells by several agents].Yakugaku Zasshi. 2000 Dec;120(12):1277-90. doi: 10.1248/yakushi1947.120.12_1277. Yakugaku Zasshi. 2000. PMID: 11193379 Review. Japanese.
Cited by
-
How to approach and treat viral infections in ICU patients.BMC Infect Dis. 2014 Nov 28;14:321. doi: 10.1186/1471-2334-14-321. BMC Infect Dis. 2014. PMID: 25431007 Free PMC article. Review.
-
A Re-emerging Respiratory Virus: Human Metapneumovirus (hMPV).Cureus. 2025 Feb 1;17(2):e78354. doi: 10.7759/cureus.78354. eCollection 2025 Feb. Cureus. 2025. PMID: 40034641 Free PMC article. Review.
-
Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model.PLoS One. 2013 Aug 28;8(8):e72529. doi: 10.1371/journal.pone.0072529. eCollection 2013. PLoS One. 2013. PMID: 24015257 Free PMC article.
-
Low-dose ribavirin treatments attenuate neuroinflammatory activation of BV-2 Cells by interfering with inducible nitric oxide synthase.Anal Cell Pathol (Amst). 2015;2015:923614. doi: 10.1155/2015/923614. Epub 2015 Aug 27. Anal Cell Pathol (Amst). 2015. PMID: 26413464 Free PMC article.
-
Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity.Hepatology. 2006 Mar;43(3):581-91. doi: 10.1002/hep.21072. Hepatology. 2006. PMID: 16496340 Free PMC article.
References
-
- Witkowsky J.T., Robins R.K., Sidwell R.W., Simon L.N. Design, synthesis and broad spectrum activity of 1,β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. JMed Chem. 1972;15:1150–1154. - PubMed
-
- Sidwell R.W., Huffman J.H., Khare G.P., Allen L.B., Witkowsky J.T., Robins R.K. Broad-spectrum antiviral activity of Virazole: 1,β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide. Science. 1972;177:705–706. - PubMed
-
- Reichard O, Yun Z.B., Sonneborg A, Weiland O. Hepatitis C viral RNA titers in serum prior to, during and after oral treatment with ribavirin for chronic hepatitis C. J Med Virol. 1993;41:99–102. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources